In our last post, we compared India's new sovereign AI, Indus by Savam, with the behemoth ChatGPT. And to our surprise, the Indus did an amazing job being a ...

New edition builds on the widely used prior version—now expanded to 530+ questions, added diagnostics, difficulty ...

Examine the MCA 2026 syllabus: a thorough overview of the essential subjects, broken down by semester, and highlighting popular specializations like artificial intelligence and cloud computing in ...

Explore the innovative concept of vibe coding and how it transforms drug discovery through natural language programming.

Master 3D electric field simulations of a charged rod using Python! 🐍⚡ This tutorial guides you step-by-step through visualizing electric field vectors in three dimensions, helping you understand ...

Learn how to create dynamic, animated graphs in GlowScript using VPython with ease! 📊 This step-by-step tutorial guides you through visualizing data, animating simulations, and mastering interactive ...

Physical AI is not merely a product feature. It is an architectural shift. The question before us is simple: Will the world of Physical AI be built by a few thousand engineers, or by millions of ...

After being laid off, this professional accepted a 50% pay cut to stay afloat. Tech salaries rose 15% in 2025. This worker ...

As artificial intelligence continues to reshape industries at an unprecedented pace, venture capitalists face a critical knowledge gap: understanding how humans and AI systems collaborate most ...

A new report has shed light on Microsoft’s Xbox plans for 2026, while confirming one unannounced game is still in the works. Amazon's Fallout TV show countdown turned out not to be Fallout 3 or ...

Aaron McKinley is a writer, blogger, and video game enthusiast with over six years of experience in web content and many more in playing games until the wee hours of the morning. A passion for writing ...

Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...